These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 18282632)

  • 1. The use of Minilabs to improve the testing capacity of regulatory authorities in resource limited settings: Tanzanian experience.
    Risha PG; Msuya Z; Clark M; Johnson K; Ndomondo-Sigonda M; Layloff T
    Health Policy; 2008 Aug; 87(2):217-22. PubMed ID: 18282632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substandard medicines in resource-poor settings: a problem that can no longer be ignored.
    Caudron JM; Ford N; Henkens M; Macé C; Kiddle-Monroe R; Pinel J
    Trop Med Int Health; 2008 Aug; 13(8):1062-72. PubMed ID: 18631318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strengthening of national capacity in implementation of antimalarial drug quality assurance in Thailand.
    Vijaykadga S; Cholpol S; Sitthimongkol S; Pawaphutanan A; Pinyoratanachot A; Rojanawatsirivet C; Kovithvattanapong R; Thimasarn K
    Southeast Asian J Trop Med Public Health; 2006; 37 Suppl 3():5-10. PubMed ID: 17547041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surveillance for falsified and substandard medicines in Africa and Asia by local organizations using the low-cost GPHF Minilab.
    Petersen A; Held N; Heide L;
    PLoS One; 2017; 12(9):e0184165. PubMed ID: 28877208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proficiency testing as a tool to assess the performance of visual TLC quantitation estimates.
    Risha P; Msuya Z; Ndomondo-Sigonda M; Layloff T
    J AOAC Int; 2006; 89(5):1300-4. PubMed ID: 17042179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Provision of information on regulatory authorities' websites.
    Vitry A; Lexchin J; Sasich L; Dupin-Spriet T; Reed T; Bertele V; Garattini S; Toop L; Hurley E
    Intern Med J; 2008 Jul; 38(7):559-67. PubMed ID: 18336542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of thin-layer chromatography to detect counterfeit sulfadoxine/pyrimethamine tablets with the wrong active ingredient in Malawi.
    Khuluza F; Kigera S; Jähnke RW; Heide L
    Malar J; 2016 Apr; 15():215. PubMed ID: 27075749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helping your patients avoid counterfeit medicines.
    Teichman PG
    Fam Pract Manag; 2007 Mar; 14(3):33-5. PubMed ID: 17408128
    [No Abstract]   [Full Text] [Related]  

  • 9. Integrated Diseases Surveillance Project (IDSP) through a consultant's lens.
    Suresh K
    Indian J Public Health; 2008; 52(3):136-43. PubMed ID: 19189835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-malarial drug quality in Lagos and Accra - a comparison of various quality assessments.
    Bate R; Hess K
    Malar J; 2010 Jun; 9():157. PubMed ID: 20537190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Human resource capacity building on TB laboratory work for TB control program--through the experience of international TB laboratory training course for TB control at the Research Institute of Tuberculosis, JATA, Japan].
    Fujiki A; Kato S
    Kekkaku; 2008 Jun; 83(6):475-9. PubMed ID: 18634453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Counterfeit and substandard antimalarial drugs in Cambodia.
    Lon CT; Tsuyuoka R; Phanouvong S; Nivanna N; Socheat D; Sokhan C; Blum N; Christophel EM; Smine A
    Trans R Soc Trop Med Hyg; 2006 Nov; 100(11):1019-24. PubMed ID: 16765399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulators scramble to tighten loopholes after heparin debacle.
    Jia H
    Nat Biotechnol; 2008 May; 26(5):477-8. PubMed ID: 18464756
    [No Abstract]   [Full Text] [Related]  

  • 14. Post-marketing strategies for medicines.
    Breckenridge A
    Clin Pharmacol Ther; 2008 Jan; 83(1):24-5; discussion 25. PubMed ID: 18043682
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevalence of counterfeit anthelminthic medicines: a cross-sectional survey in Cambodia.
    Khan MH; Okumura J; Sovannarith T; Nivanna N; Akazawa M; Kimura K
    Trop Med Int Health; 2010 May; 15(5):639-44. PubMed ID: 20214756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality assessment of internet pharmaceutical products using traditional and non-traditional analytical techniques.
    Westenberger BJ; Ellison CD; Fussner AS; Jenney S; Kolinski RE; Lipe TG; Lyon RC; Moore TW; Revelle LK; Smith AP; Spencer JA; Story KD; Toler DY; Wokovich AM; Buhse LF
    Int J Pharm; 2005 Dec; 306(1-2):56-70. PubMed ID: 16266793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using VigiBase to Identify Substandard Medicines: Detection Capacity and Key Prerequisites.
    Juhlin K; Karimi G; Andér M; Camilli S; Dheda M; Har TS; Isahak R; Lee SJ; Vaughan S; Caduff P; Norén GN
    Drug Saf; 2015 Apr; 38(4):373-82. PubMed ID: 25687792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post marketing surveillance of selected veterinary medicines in Tanzania mainland.
    Fimbo AM; Maganda BA; Mwamwitwa KW; Mwanga IE; Mbekenga EB; Kisenge S; Mziray SA; Kulwa GS; Mwalwisi YH; Shewiyo DH
    BMC Vet Res; 2022 Jun; 18(1):216. PubMed ID: 35681204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of ceftriaxone in Pakistan: reality and resonance.
    Obaid A
    Pak J Pharm Sci; 2009 Apr; 22(2):220-9. PubMed ID: 19339236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.